Skip to main content
. Author manuscript; available in PMC: 2013 Sep 1.
Published in final edited form as: Neuropharmacology. 2012 May 11;63(4):538–546. doi: 10.1016/j.neuropharm.2012.04.035

Table 3.

Cytisine and Varenicline potency and efficacy, peak current data

Cytisine Varenicline
Accessory
subunit
EC50
µM
Imax
relative to AChmax
EC50
µM
Imax
relative to AChmax
α3 1750 ± 300 0.34 ± 0.03 16 ± 5 0.54 ± 0.06
β4 214 ± 32 0.16 ± 0.01 4.5 ± 1.4 0.11 ± 0.01
α5 180 ± 8 0.17 ± 0.01 5.8 ± 0.9 0.16 ± 0.01
α5D376N 309 ± 43 0.21 ± 0.01 6.5 ± 1.5 0.15 ± 0.01